Skip to main content

Table 1.

Participant Characteristics (N = 77)

Characteristics Rurala (n = 50) Not Rurala (n = 27)
Credentials, No. (%)b
 Advanced Practice Nurse 18 (36) 6 (22)
 Physician 24 (48) 19 (70)
 Physician Assistant 7 (14) 2 (8)
 Other 1 (2) 0
Racial background, No. (%)
 Non-White 7 (14) 3 (12)
 White 40 (80) 21 (81)
 Prefer not to answer 3 (6) 2 (8)
 Missing 0 1
Sex, No. (%)
 Female 30 (63) 16 (59)
 Male 15 (31) 8 (30)
 Sex variant/nonconforming 0 1 (4)
 Prefer not to answer 3 (6) 2 (7)
 Missing 2 0
Spanish, Hispanic, or Latino, No. (%)
 Yes 1 (2) 0
 No 43 (90) 25 (93)
 Prefer not to answer 4 (8) 2 (7)
 Missing 2 0
Average years of practice, mean ± SD 18.3 ± 12.6 18.7 ± 12.8
Days per week subjects see patients, No. (%)
 ≤3.5 15 (30) 10 (40)
 >4 35 (70) 15 (60)
 Missing 0 2
Leadership role
 No 31 (63) 17 (63)
 Yes 18 (37) 10 (37)
 Missing 1 0
 Medical director 6 (35) 6 (60)
 Quality improvement 1 (6) 0
 Other 10 (59) 4 (40)
 Missing 1 0
Type of lung cancer screening referrals made, No. (%)
 LDCT only 29 (58) 17 (63)
 LDCT and other screening methods 14 (28) 7 (26)
 Other screening methods 7 (14) 3 (11)
Average no. of LDCT referrals made per month, No. (%)
 0 11 (23) 6 (22)
 1-3 28 (58) 16 (59)
 4-6 6 (13) 5 (19)
 ≥7 3 (6) 0
 Missing 2 0
Do you refer outside of primary location? Yes, No. (%) 13 (29) 18 (69)
No. of subjects who indicated they refer patients for LDCT screening based on the following indications,c No. (%)
 Patient’s preference 33 20
 Closest location 32 15
 Patient’s insurance 23 22
 My institution 18 4
 Affiliated institution 7 3
 Other 5 5
 Reputation 3 1
 Personal connection 2 0
How many providers chose at least one of the top three reasons? No. (%) 33 (66) 21 (78)
Type of reminder used to determine eligibility for lung cancer screening, No. (%)
 EHR reminder 31 (66) 19 (68)
 No reminders, alerts, or flags 13 (28) 7 (25)
 Other platform 2 () 2 (7)
 Don’t know 1 (2) 0
 Missing 3 0
Role of staff within lung cancer screening, No. (%)
 Who does the shared decision-making interaction when the patient decides whether to get lung cancer screening?
 Respondent 43 (96) 25 (96)
 Clinic staff 2 (4) 1 (4)
 Radiology facility 0 0
 No one 0 0
 I don’t know 0 0
 Other 0 0
 Missing 5 1
 Who is responsible for follow up with patients to ensure they complete their baseline LDCT scan? No. (%)
 Respondent 12 (27) 7 (27)
 Clinic staff 20 (44) 12 (46)
 Radiology facility 4 (9) 0
 No one 8 (18) 5 (19)
 I don’t know 1 (2) 2 (8)
 Other 0 0
 Missing 5 1
 Who makes sure that patients follow the recommendations from the baseline LDCT scan?d No. (%)
 Respondent 28 (64) 19 (73)
 Clinic staff 11 (25) 3 (12)
 Radiology facility 3 (7) 2 (8)
 No one 1 (2) 0
 I don’t know 1 (2) 1 (4)
 Other 0 1 (4)
 Missing 6 1
 Who ensures patients are not lost to follow up?e No. (%)
 Respondent 11 (24) 5 (19)
 Clinic staff 18 (40) 9 (35)
 Radiology facility 2 (4) 5 (19)
 No one 10 (22) 4 (15)
 I don’t know 3 (7) 3 (12)
 Other 1 (2) 0
 Missing 5 1
 Who refers a patient to other providers when the LDCT result suggests lung cancer?f No. (%)
 Respondent 42 (93) 25 (96)
 Clinic staff 3 (7) 1 (4)
 Radiology facility 0 0
 No one 0 0
 I don’t know 0 0
 Other 0 0
 Missing 5 1
 Who uses a registry (paper or electronic) to track patients who undergo LDCT lung cancer screening?g No. (%)
 Respondent 0 1 (4)
 Clinic staff 9 (22) 4 (16)
 Radiology facility 4 (10) 3 (12)
 No one 17 (41) 11 (44)
 I don’t know 9 (22) 6 (24)
 Other 2 (5) 0
 Missing 9 2

LDCT = low-dose CT.

a

We determined rurality using facility zip codes and Oregon Health Department rurality designation data.

b

Contains nonmissing data and may not equal 100% because of rounding.

c

Subjects were allowed to pick their top three reasons.

d

A patient has a nodule found on the initial scan and is recommended to receive a 6-month follow-up LDCT.

e

The patient comes back for the annual LDCT scan.

f

Referring a patient to a pulmonologist for a nodule.

g

More than 10% missing responses.